ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Targeted Focal Laser Ablation for Prostate Cancer
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 268736" data-attributes="member: 13851"><p>[MEDIA=youtube]qO21VrIhwaQ[/MEDIA]</p><p></p><p></p><p><em><strong>We are delighted to team up with <u>Clinical Laserthermia Systems</u> Americas this week for a groundbreaking episode where we dive into the world of <u>cutting-edge medical technology</u> and shed light on an <u>emerging innovation that promises to revolutionize the management of prostate cancer</u>! </strong></em></p><p><em><strong></strong></em></p><p><em><strong>CLS is a leading medical device company at the forefront of pioneering precise and effective interventional healthcare solutions. They have developed an <u>innovative CLS thermal therapy system for image-guided focal laser ablation that spares healthy tissue while minimizing the debilitating side effects often associated with traditional treatments</u>. This technology can even be administered by a urologist in an office setting, bringing hope and convenience to countless patients. </strong></em></p><p><em><strong></strong></em></p><p><em><strong>We are honored to have <u>Michael Magnani, the President of CLS</u>, joining us today to explore their <u>new thermal therapy system for image-guided focal laser ablation</u>. With a career spanning over two decades in corporate management within the life sciences industry, he brings a wealth of expertise in product development, corporate strategy, business development, and commercialization. He graduated from the unique Biomedical Enterprise Program at the MIT Sloan School of Management and holds a Bachelor of Science in Microbiology from the University of California, San Diego. </strong></em></p><p><em><strong></strong></em></p><p><strong><em>Join us to learn about the exciting possibilities this <u>transformative new technology holds for the future of prostate cancer management</u>!</em></strong></p><p><strong><em></em></strong></p><p><strong><em>Show highlights: </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*Michael discusses what they are doing at CLS </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*The benefits of offering targeted focal therapy as an alternative treatment for prostate cancer </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*Michael walks through the device components of the CLS thermal therapy system, explaining how it works in targeting prostate cancer and how it gets deployed within a urological setting </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*What are the advantages of using targeted focal laser ablation for prostate cancer? </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*Who would be considered an appropriate candidate for CLS thermal therapy? </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*Some of the potential risks associated with focal laser ablation treatment </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*How the CLS mobile services model works for a urologist practice </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*How can adopting a concierge business model allow urologists to provide early access to some emerging technologies? </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*What can a patient expect during the procedure and in the recovery phase? </em></strong></p><p><strong><em></em></strong></p><p><strong><em></em></strong></p><p><strong><em></em></strong></p><p><strong><em></em></strong></p><p><strong><em>The strides made by CLS in developing its CLS thermal therapy system for image-guided focal laser ablation offer hope for countless patients. The future of prostate cancer management is undoubtedly brighter with innovations like these, and we invite you to tune into future episodes where we will continue to explore the new and transformative possibilities that lie ahead. </em></strong></p></blockquote><p></p>
[QUOTE="madman, post: 268736, member: 13851"] [MEDIA=youtube]qO21VrIhwaQ[/MEDIA] [I][B]We are delighted to team up with [U]Clinical Laserthermia Systems[/U] Americas this week for a groundbreaking episode where we dive into the world of [U]cutting-edge medical technology[/U] and shed light on an [U]emerging innovation that promises to revolutionize the management of prostate cancer[/U]! CLS is a leading medical device company at the forefront of pioneering precise and effective interventional healthcare solutions. They have developed an [U]innovative CLS thermal therapy system for image-guided focal laser ablation that spares healthy tissue while minimizing the debilitating side effects often associated with traditional treatments[/U]. This technology can even be administered by a urologist in an office setting, bringing hope and convenience to countless patients. We are honored to have [U]Michael Magnani, the President of CLS[/U], joining us today to explore their [U]new thermal therapy system for image-guided focal laser ablation[/U]. With a career spanning over two decades in corporate management within the life sciences industry, he brings a wealth of expertise in product development, corporate strategy, business development, and commercialization. He graduated from the unique Biomedical Enterprise Program at the MIT Sloan School of Management and holds a Bachelor of Science in Microbiology from the University of California, San Diego. [/B][/I] [B][I]Join us to learn about the exciting possibilities this [U]transformative new technology holds for the future of prostate cancer management[/U]! Show highlights: *Michael discusses what they are doing at CLS *The benefits of offering targeted focal therapy as an alternative treatment for prostate cancer *Michael walks through the device components of the CLS thermal therapy system, explaining how it works in targeting prostate cancer and how it gets deployed within a urological setting *What are the advantages of using targeted focal laser ablation for prostate cancer? *Who would be considered an appropriate candidate for CLS thermal therapy? *Some of the potential risks associated with focal laser ablation treatment *How the CLS mobile services model works for a urologist practice *How can adopting a concierge business model allow urologists to provide early access to some emerging technologies? *What can a patient expect during the procedure and in the recovery phase? The strides made by CLS in developing its CLS thermal therapy system for image-guided focal laser ablation offer hope for countless patients. The future of prostate cancer management is undoubtedly brighter with innovations like these, and we invite you to tune into future episodes where we will continue to explore the new and transformative possibilities that lie ahead. [/I][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Targeted Focal Laser Ablation for Prostate Cancer
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top